Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy

被引：0
|
作者：
Takako Inoue
Madoka Kimura
Junji Uchida
Kazumi Nishino
Toru Kumagai
Junko Taniguchi
Fumio Imamura
机构：
[1] Osaka Medical Center for Cancer and Cardiovascular Disease,Department of Thoracic Oncology
[2] Osaka Medical Center for Cancer and Cardiovascular Disease,Nursing Department
来源：
International Journal of Clinical Oncology | 2017年 / 22卷
关键词：
Aprepitant; Breakthrough emesis; Moderately emetogenic chemotherapy; Lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：600 / 604
页数：4
相关论文
共 50 条
  • [41] Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and Vomiting
    Navari, Rudolph M.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [42] Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
    Escobar, Yolanda
    Cajaraville, Gerardo
    Antonio Virizuela, Juan
    Alvarez, Rosa
    Munoz, Andres
    Olariaga, Olatz
    Jose Tames, Maria
    Muros, Begona
    Jose Lecumberri, Maria
    Feliu, Jaime
    Martinez, Purificacion
    Carlos Adansa, Juan
    Jose Martinez, Maria
    Lopez, Rafael
    Blasco, Ana
    Gascon, Pere
    Calvo, Virginia
    Luna, Pablo
    Montalar, Joaquin
    Del Barrio, Patricia
    Victoria Tornamira, Maria
    SUPPORTIVE CARE IN CANCER, 2015, 23 (09) : 2833 - 2840
  • [43] Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
    Yolanda Escobar
    Gerardo Cajaraville
    Juan Antonio Virizuela
    Rosa Álvarez
    Andrés Muñoz
    Olatz Olariaga
    María José Tamés
    Begoña Muros
    María Jose Lecumberri
    Jaime Feliu
    Purificación Martínez
    Juan Carlos Adansa
    María José Martínez
    Rafael López
    Ana Blasco
    Pere Gascón
    Virginia Calvo
    Pablo Luna
    Joaquín Montalar
    Patricia Del Barrio
    María Victoria Tornamira
    Supportive Care in Cancer, 2015, 23 : 2833 - 2840
  • [44] A phase II, randomized study of aprepitant in the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients
    Aridome, Kuniaki
    Mori, Shin-Ichirou
    Baba, Kenji
    Yanagi, Masayuki
    Hamanoue, Masahiro
    Miyazono, Futoshi
    Tokuda, Kouki
    Imamura, Hiroshi
    Ogura, Yoshito
    Kaneko, Kouichi
    Kijima, Fumio
    Maemura, Kousei
    Ishigami, Sumiya
    Natsugoe, Shoji
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (03) : 393 - 398
  • [45] Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers
    Gralla, R.
    Rapoport, B.
    Brown, C.
    Street, J. C.
    Hardwick, J. S.
    Carides, A. D.
    EJC SUPPLEMENTS, 2009, 7 (03): : 23 - 24
  • [46] A retrospective study on chemotherapy-induced nausea and vomiting in highly/moderately emetogenic chemotherapy: incidence and prescribing practice
    Nurul Suhaida Badarudin
    Noraida Mohamed Shah
    Kamarun Neasa Begam Mohd Kassim
    Fuad Ismail
    Farida Islahudin
    Nurul Ain Mohd Tahir
    Suhana Yusak
    Supportive Care in Cancer, 2022, 30 : 5339 - 5349
  • [47] A retrospective study on chemotherapy-induced nausea and vomiting in highly/moderately emetogenic chemotherapy: incidence and prescribing practice
    Badarudin, Nurul Suhaida
    Shah, Noraida Mohamed
    Kassim, Kamarun Neasa Begam Mohd
    Ismail, Fuad
    Islahudin, Farida
    Tahir, Nurul Ain Mohd
    Yusak, Suhana
    SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 5339 - 5349
  • [48] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy
    Herrstedt, J
    Muss, HB
    Warr, DG
    Hesketh, PJ
    Eisenberg, PD
    Raftopoulos, H
    Grunberg, SM
    Gabriel, M
    Rodgers, A
    Hustad, CM
    Horgan, KJ
    Skobieranda, F
    CANCER, 2005, 104 (07) : 1548 - 1555
  • [49] Prevalence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy in platinum-based regimens.
    Shah, Nilomi
    Nishimura, Kris
    Tan, Evelyn
    Hsu, Hana
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Likelihood of a subsequent chemotherapy-induced nausea and vomiting (CINV) event in patients receiving low, moderately or highly emetogenic chemotherapy (LEC/MEC/HEC)
    Schwartzberg, Lee
    Szabo, Stephen
    Gilmore, James
    Haislip, Sally
    Jackson, James
    Jain, Gagan
    Balu, Sanjeev
    Buchner, Deborah
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) : 837 - 845
12345